Acceptability of a Tenofovir Disoproxil Fumarate Vaginal Ring for HIV Prevention Among Women in New York City

Dana Watnick, Marla J. Keller, Kimberly Stein, Laurie J. Bauman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Vaginal rings for pre-exposure prophylaxis are a female-initiated HIV prevention method that does not require daily or coitally-dependent dosing. As part of a randomized placebo-controlled trial of a tenofovir disoproxil fumarate intravaginal ring, we assessed product acceptability through in-depth interviews with 18 women during and after 14 days of continuous use. Women reported that the ring was comfortable with few side effects, regardless of experimental arm. However, interest in future use by this cohort was modest for several reasons including: low self-perceived HIV risk; concern that use implied promiscuity; potential for interference with relationship formation and trust; concern for interference with menstruation and cleanliness; and worries about partners’ acceptability and sexual pleasure. Potential issues were raised with duration of use prior to ring exchange. Future studies should continue to identify and address individual and relationship factors that influence acceptability, early in the product development process.

Original languageEnglish (US)
Pages (from-to)1-16
Number of pages16
JournalAIDS and Behavior
DOIs
StateAccepted/In press - Nov 16 2017

Fingerprint

Tenofovir
Female Contraceptive Devices
HIV
Pleasure
Menstruation
Sexual Partners
Randomized Controlled Trials
Placebos
Interviews

Keywords

  • Acceptability
  • HIV prevention
  • Pre-exposure prophylaxis
  • Vaginal ring
  • Women

ASJC Scopus subject areas

  • Social Psychology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Acceptability of a Tenofovir Disoproxil Fumarate Vaginal Ring for HIV Prevention Among Women in New York City. / Watnick, Dana; Keller, Marla J.; Stein, Kimberly; Bauman, Laurie J.

In: AIDS and Behavior, 16.11.2017, p. 1-16.

Research output: Contribution to journalArticle

@article{684709e536264be99c79dfb638476dba,
title = "Acceptability of a Tenofovir Disoproxil Fumarate Vaginal Ring for HIV Prevention Among Women in New York City",
abstract = "Vaginal rings for pre-exposure prophylaxis are a female-initiated HIV prevention method that does not require daily or coitally-dependent dosing. As part of a randomized placebo-controlled trial of a tenofovir disoproxil fumarate intravaginal ring, we assessed product acceptability through in-depth interviews with 18 women during and after 14 days of continuous use. Women reported that the ring was comfortable with few side effects, regardless of experimental arm. However, interest in future use by this cohort was modest for several reasons including: low self-perceived HIV risk; concern that use implied promiscuity; potential for interference with relationship formation and trust; concern for interference with menstruation and cleanliness; and worries about partners’ acceptability and sexual pleasure. Potential issues were raised with duration of use prior to ring exchange. Future studies should continue to identify and address individual and relationship factors that influence acceptability, early in the product development process.",
keywords = "Acceptability, HIV prevention, Pre-exposure prophylaxis, Vaginal ring, Women",
author = "Dana Watnick and Keller, {Marla J.} and Kimberly Stein and Bauman, {Laurie J.}",
year = "2017",
month = "11",
day = "16",
doi = "10.1007/s10461-017-1962-8",
language = "English (US)",
pages = "1--16",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",

}

TY - JOUR

T1 - Acceptability of a Tenofovir Disoproxil Fumarate Vaginal Ring for HIV Prevention Among Women in New York City

AU - Watnick, Dana

AU - Keller, Marla J.

AU - Stein, Kimberly

AU - Bauman, Laurie J.

PY - 2017/11/16

Y1 - 2017/11/16

N2 - Vaginal rings for pre-exposure prophylaxis are a female-initiated HIV prevention method that does not require daily or coitally-dependent dosing. As part of a randomized placebo-controlled trial of a tenofovir disoproxil fumarate intravaginal ring, we assessed product acceptability through in-depth interviews with 18 women during and after 14 days of continuous use. Women reported that the ring was comfortable with few side effects, regardless of experimental arm. However, interest in future use by this cohort was modest for several reasons including: low self-perceived HIV risk; concern that use implied promiscuity; potential for interference with relationship formation and trust; concern for interference with menstruation and cleanliness; and worries about partners’ acceptability and sexual pleasure. Potential issues were raised with duration of use prior to ring exchange. Future studies should continue to identify and address individual and relationship factors that influence acceptability, early in the product development process.

AB - Vaginal rings for pre-exposure prophylaxis are a female-initiated HIV prevention method that does not require daily or coitally-dependent dosing. As part of a randomized placebo-controlled trial of a tenofovir disoproxil fumarate intravaginal ring, we assessed product acceptability through in-depth interviews with 18 women during and after 14 days of continuous use. Women reported that the ring was comfortable with few side effects, regardless of experimental arm. However, interest in future use by this cohort was modest for several reasons including: low self-perceived HIV risk; concern that use implied promiscuity; potential for interference with relationship formation and trust; concern for interference with menstruation and cleanliness; and worries about partners’ acceptability and sexual pleasure. Potential issues were raised with duration of use prior to ring exchange. Future studies should continue to identify and address individual and relationship factors that influence acceptability, early in the product development process.

KW - Acceptability

KW - HIV prevention

KW - Pre-exposure prophylaxis

KW - Vaginal ring

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=85034263482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034263482&partnerID=8YFLogxK

U2 - 10.1007/s10461-017-1962-8

DO - 10.1007/s10461-017-1962-8

M3 - Article

C2 - 29147810

AN - SCOPUS:85034263482

SP - 1

EP - 16

JO - AIDS and Behavior

JF - AIDS and Behavior

SN - 1090-7165

ER -